| Autor: |
Gerber PF; Animal Science, School of Environmental and Rural Science, University of New England, Armidale, New South Wales 2351, Australia, pgerber2@une.edu.au., Spatz S; U.S. Department of Agriculture, Agricultural Research Service, U.S. National Poultry Research Center, Athens, GA 30605., Gray P; Inghams Enterprises P/L, Morisset, New South Wales 2264, Australia., Alfirevich S; Baiada Poultry, Pendle Hill, New South Wales 2145, Australia., Walkden-Brown SW; Animal Science, School of Environmental and Rural Science, University of New England, Armidale, New South Wales 2351, Australia. |
| Abstrakt: |
Currently, there is no available vaccine against hemorrhagic enteritis virus (HEV) in Australia. Although it is assumed that subclinical HEV infections occur and may be associated with an increase in colibacillosis in Australian commercial turkey flocks, the prevalence of infection with this virus in the country is largely unknown. The aims of this study were to determine the extent of HEV infection in commercial flocks in Australia and to investigate the diversity of Australian HEV strains. Serum and spleen samples were collected from breeder and grower turkeys and serum was collected from breeder and grower chickens by the two major poultry integrator companies in Australia. Of the turkey samples, 727/849 (86%) sera were positive for anti-HEV antibodies by ELISA. HEV DNA was detected in 215/278 (77%) spleen samples positive by PCR. Of the meat chicken sera, 115/144 (80%) samples were seropositive. Sequencing the whole genome of three HEV field isolates showed that the Australian strains are highly similar and cluster separately from strains from other geographic regions although several point mutations were shared with HEV strains considered to be virulent. In conclusion, HEV infection is ubiquitous in Australian commercial poultry flocks. The impact of the many genomic point mutations detected in Australian HEV strains on virus pathogenicity is unclear. |
